SURG Financial Statements

Balance sheet, income statement, cash flow, and dividends for Surgepays Inc (SURG).


$35.89M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

SURG Market Cap. (MRY)


SURG Shares Outstanding (MRY)


SURG Assets (MRY)


Total Assets

$23.98M

Total Liabilities

$8.71M

Total Investments

$176.85K

SURG Income (MRY)


Revenue

$60.88M

Net Income

-$45.73M

Operating Expense

$27.46M

SURG Cash Flow (MRY)


CF Operations

-$21.31M

CF Investing

-$3.00M

CF Financing

$22.48M

SURG Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SURG Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$23,976,005 (-42.81%)

$41,925,307 (23.30%)

$34,003,506 (74.38%)

$19,500,202 (166.21%)

Assets Current

$17,870,323 (-46.44%)

$33,366,661 (21.05%)

$27,563,785 (98.41%)

$13,892,681 (1010.50%)

Assets Non-Current

$6,105,682 (-28.66%)

$8,558,646 (32.90%)

$6,439,721 (14.84%)

$5,607,521 (-7.68%)

Goodwill & Intangible Assets

$4,772,962 (10.16%)

$4,332,676 (-10.37%)

$4,833,939 (12.41%)

$4,300,266 (-13.87%)

Shareholders Equity

$15,315,919 (-45.78%)

$28,249,220 (466.04%)

$4,990,718 (40.53%)

$3,551,321 (133.11%)

Property Plant & Equipment Net

$1,155,869 (54.18%)

$749,710 (-30.24%)

$1,074,725 (56.41%)

$687,116 (13.49%)

Cash & Equivalents

$12,790,389 (-12.53%)

$14,622,060 (107.83%)

$7,035,654 (11.97%)

$6,283,496 (832.28%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$20,000 (-91.77%)

$243,110 (-12.00%)

$276,250 (-37.68%)

Total Investments

$176,851 (-72.42%)

$641,260 (20.75%)

$531,057 (-14.36%)

$620,139 (49.57%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$176,851 (-72.42%)

$641,260 (20.75%)

$531,057 (-14.36%)

$620,139 (49.57%)

Inventory

$1,781,365 (-80.31%)

$9,046,594 (-19.13%)

$11,186,242 (156.61%)

$4,359,296 (2344.80%)

Trade & Non-Trade Receivables

$3,000,209 (-68.54%)

$9,536,074 (3.31%)

$9,230,365 (184.02%)

$3,249,889 (1700.50%)

Trade & Non-Trade Payables

$4,122,040 (-44.95%)

$7,487,344 (-0.34%)

$7,513,095 (-6.00%)

$7,992,375 (-6.86%)

Accumulated Retained Earnings (Deficit)

-$60,915,427 (-301.12%)

-$15,186,203 (57.59%)

-$35,804,106 (-1.94%)

-$35,123,343 (-62.67%)

Tax Assets

$0 (0%)

$2,835,000 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$570,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$4,592,352 (-15.65%)

$5,444,499 (-32.87%)

$8,110,864 (5.61%)

$7,680,256 (0.15%)

Debt Current

$1,937,436 (-58.13%)

$4,627,700 (72.05%)

$2,689,673 (55.51%)

$1,729,569 (-67.23%)

Debt Non-Current

$2,654,916 (225.04%)

$816,799 (-84.93%)

$5,421,191 (-8.90%)

$5,950,687 (148.95%)

Total Liabilities

$8,714,392 (-35.55%)

$13,521,843 (-53.19%)

$28,885,253 (81.11%)

$15,948,881 (-11.65%)

Liabilities Current

$6,059,476 (-52.31%)

$12,705,044 (-45.85%)

$23,464,062 (134.68%)

$9,998,194 (-36.16%)

Liabilities Non-Current

$2,654,916 (225.04%)

$816,799 (-84.93%)

$5,421,191 (-8.90%)

$5,950,687 (148.95%)

SURG Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$60,881,173 (-55.61%)

$137,141,832 (12.83%)

$121,544,190 (138.04%)

$51,060,589 (-6.15%)

Cost of Revenue

$75,205,372 (-25.91%)

$101,499,341 (-6.08%)

$108,074,782 (140.75%)

$44,890,610 (-13.57%)

Selling General & Administrative Expense

$27,458,152 (63.66%)

$16,777,107 (30.71%)

$12,835,623 (5.53%)

$12,162,547 (-3.58%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$27,458,152 (63.66%)

$16,777,107 (30.71%)

$12,835,623 (5.53%)

$12,162,547 (-3.58%)

Interest Expense

$554,200 (-7.01%)

$595,975 (-67.67%)

$1,843,396 (-52.00%)

$3,840,616 (-20.01%)

Income Tax Expense

$2,870,000 (226.71%)

-$2,265,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$45,937,774 (-322.52%)

$20,644,612 (3831.66%)

-$553,228 (95.91%)

-$13,531,144 (-26.20%)

Net Income to Non-Controlling Interests

-$208,550 (-880.82%)

$26,709 (-79.06%)

$127,535 (0%)

$0 (0%)

Net Income

-$45,729,224 (-321.79%)

$20,617,903 (3128.65%)

-$680,763 (94.97%)

-$13,531,144 (-26.20%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$45,729,224 (-321.79%)

$20,617,903 (3128.65%)

-$680,763 (94.97%)

-$13,531,144 (-26.20%)

Weighted Average Shares

$19,119,181 (34.09%)

$14,258,172 (15.03%)

$12,395,364 (182.89%)

$4,381,709 (105.29%)

Weighted Average Shares Diluted

$19,119,181 (28.12%)

$14,922,881 (20.39%)

$12,395,364 (182.89%)

$4,381,709 (105.29%)

Earning Before Interest & Taxes (EBIT)

-$42,305,024 (-323.26%)

$18,948,878 (1529.82%)

$1,162,633 (112.00%)

-$9,690,528 (-63.69%)

Gross Profit

-$14,324,199 (-140.19%)

$35,642,491 (164.62%)

$13,469,408 (118.31%)

$6,169,979 (149.93%)

Operating Income

-$41,782,351 (-321.48%)

$18,865,384 (2876.62%)

$633,785 (110.58%)

-$5,992,568 (40.93%)

SURG Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$3,004,576 (-968.09%)

-$281,304 (81.23%)

-$1,498,582 (-297.79%)

-$376,724 (-4609.50%)

Net Cash Flow from Financing

$22,483,508 (1029.21%)

-$2,419,635 (-266.02%)

$1,457,468 (-93.15%)

$21,274,486 (357.94%)

Net Cash Flow from Operations

-$21,310,603 (-307.15%)

$10,287,345 (1196.82%)

$793,272 (105.19%)

-$15,288,261 (-253.40%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,831,671 (-124.14%)

$7,586,406 (908.62%)

$752,158 (-86.59%)

$5,609,501 (1610.45%)

Net Cash Flow - Business Acquisitions and Disposals

-$2,500,000 (0%)

$0 (0%)

-$800,000 (-145.91%)

-$325,316 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$13,613 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$518,189 (-84.21%)

-$281,304 (59.73%)

-$698,582 (-1258.90%)

-$51,408 (-678.32%)

Issuance (Repayment) of Debt Securities

-$1,538,776 (41.42%)

-$2,626,875 (-280.29%)

$1,456,995 (-33.71%)

$2,197,776 (-46.10%)

Issuance (Purchase) of Equity Shares

$25,417,284 (12164.66%)

$207,240 (43713.95%)

$473 (-100.00%)

$21,299,662 (3646.64%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,779,835 (260.81%)

$2,433,359 (1629.76%)

$140,676 (3834.99%)

$3,575 (-98.05%)

Depreciation Amortization & Accretion

$1,292,250 (16.67%)

$1,107,582 (12.02%)

$988,700 (7.76%)

$917,468 (-33.07%)

SURG Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-23.50% (-190.38%)

26.00% (134.23%)

11.10% (-8.26%)

12.10% (168.89%)

Profit Margin

-75.10% (-600.67%)

15.00% (2600.00%)

-0.60% (97.74%)

-26.50% (-34.52%)

EBITDA Margin

-67.40% (-561.64%)

14.60% (711.11%)

1.80% (110.47%)

-17.20% (-104.76%)

Return on Average Equity (ROAE)

-121.40% (-215.07%)

105.50% (492.19%)

-26.90% (-113.28%)

202.60% (58.16%)

Return on Average Assets (ROAA)

-95.50% (-291.77%)

49.80% (2175.00%)

-2.40% (98.04%)

-122.20% (1.77%)

Return on Sales (ROS)

-69.50% (-603.62%)

13.80% (1280.00%)

1.00% (105.26%)

-19.00% (-74.31%)

Return on Invested Capital (ROIC)

-324.80% (-352.17%)

128.80% (794.44%)

14.40% (101.13%)

-1278.70% (-602.63%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.74 (-116.75%)

4.45 (103.39%)

-131.2 (-19961.16%)

-0.65 (44.34%)

Price to Sales Ratio (P/S)

0.56 (-16.69%)

0.67 (0.30%)

0.67 (286.71%)

0.17 (-25.11%)

Price to Book Ratio (P/B)

2.34 (-27.89%)

3.25 (-80.27%)

16.47 (140.38%)

6.85 (623.85%)

Debt to Equity Ratio (D/E)

0.57 (18.79%)

0.48 (-91.72%)

5.79 (28.88%)

4.49 (366.84%)

Earnings Per Share (EPS)

-2.39 (-264.83%)

1.45 (3000.00%)

-0.05 (98.38%)

-3.09 (38.45%)

Sales Per Share (SPS)

3.18 (-66.90%)

9.62 (-1.92%)

9.81 (-15.85%)

11.65 (-54.28%)

Free Cash Flow Per Share (FCFPS)

-1.14 (-262.68%)

0.7 (8675.00%)

0.01 (100.23%)

-3.5 (-72.46%)

Book Value Per Share (BVPS)

0.8 (-59.57%)

1.98 (391.56%)

0.4 (-50.25%)

0.81 (116.12%)

Tangible Assets Book Value Per Share (TABVPS)

1 (-61.93%)

2.64 (12.07%)

2.35 (-32.17%)

3.47 (217.38%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (-125.00%)

4 (-94.74%)

76 (2000.00%)

-4 (-33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.65 (-115.46%)

4.22 (-89.70%)

40.94 (1137.58%)

-3.95 (13.33%)

Asset Turnover

1.27 (-61.58%)

3.31 (-21.91%)

4.24 (-8.03%)

4.61 (-26.98%)

Current Ratio

2.95 (12.30%)

2.63 (123.49%)

1.18 (-15.47%)

1.39 (1637.50%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$21,828,792 (-318.16%)

$10,006,041 (10467.16%)

$94,690 (100.62%)

-$15,339,669 (-254.05%)

Enterprise Value (EV)

$26,723,157 (-68.40%)

$84,562,249 (-4.00%)

$88,081,755 (154.43%)

$34,618,917 (67.12%)

Earnings Before Tax (EBT)

-$42,859,224 (-333.53%)

$18,352,903 (2795.93%)

-$680,763 (94.97%)

-$13,531,144 (-26.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$41,012,774 (-304.49%)

$20,056,460 (832.28%)

$2,151,333 (124.52%)

-$8,773,060 (-92.84%)

Invested Capital

$4,945,530 (-68.52%)

$15,710,026 (131.69%)

$6,780,715 (2.76%)

$6,598,502 (204.19%)

Working Capital

$11,810,847 (-42.84%)

$20,661,617 (403.98%)

$4,099,723 (5.27%)

$3,894,487 (127.03%)

Tangible Asset Value

$19,203,043 (-48.92%)

$37,592,631 (28.88%)

$29,169,567 (91.91%)

$15,199,936 (551.65%)

Market Capitalization

$35,887,554 (-60.89%)

$91,771,903 (11.64%)

$82,202,888 (237.81%)

$24,333,987 (73.39%)

Average Equity

$37,669,076 (92.81%)

$19,536,828 (671.16%)

$2,533,426 (137.93%)

-$6,679,193 (20.19%)

Average Assets

$47,866,493 (15.57%)

$41,418,636 (44.50%)

$28,663,982 (158.78%)

$11,076,662 (28.54%)

Invested Capital Average

$13,024,139 (-11.49%)

$14,714,334 (82.15%)

$8,078,192 (965.94%)

$757,846 (132.56%)

Shares

20,161,547 (41.70%)

14,228,202 (13.54%)

12,530,928 (4.02%)

12,046,528 (406.42%)